NCT Number: NCT02079168
A Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults
To evaluate the effectiveness of RXI-109 in reducing the recurrence of keloid formation following elective keloid excision.
Looking for future studies?
Notify MeKey information
Conditions
Age range
21 year–55 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Primary location
San Cristobal, Dominican Republic
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Adults, 21-55 years of age.
- Two keloids of approximately similar size and anatomical location on the earlobe, neck, or torso.
- Keloids to be excised must have been present for > 1 year.
Exclusion criteria
- Use of tobacco or nicotine-containing products
- Pregnant or lactating
- Post-menopausal or full hysterectomy
Treatment and study plan
Placebo
DrugPrimary outcomes
-
Reduction in the recurrence of a keloid after keloid excision
Time frame: 6 months
To evaluate the effectiveness of RXI-109 in reducing the recurrence of keloid formation following elective keloid excision
Secondary outcomes
-
Safety of RXI-109
Time frame: 6 months
To assess severity and frequency of reported adverse events and clinically-relevant changes in laboratory testing after elective excision of a keloid
Sponsors and collaborators
Lead sponsor
RXi Pharmaceuticals, Corp.
Industry
Registry information
Official study title
A Multi-Center, Prospective, Randomized, Single-Blind, Within-Subject Controlled, Phase 2a Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults
Important dates
- Study start
- 2014
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Mar 5, 2014
- Registry last updated
- Jun 14, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Tattooing and Piercing Among Medical Students
NCT07673484
Allergic Contact Dermatitis, Cicatrix
Küçükçekmece, Istanbul, Turkey (Türkiye)
View Trial DetailsStudy to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids
NCT05128383
Cicatrix, Cicatrix, Hypertrophic
Boston, Massachusetts, United States
View Trial DetailsSafety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy
NCT04827875
Cicatrix, Collagen Diseases
Encinitas, California, United States
View Trial DetailsPhotobiomodulation and the Intralesional Administration of Corticoid in the Keloid Surgery.
NCT04824612
Cicatrix, Collagen Diseases
São Paulo, Brazil
View Trial Details